UPDATE : Tuesday, August 22, 2017
상단여백
Celltrion’s move to main stock market draws investor concern
The recent decision by Celltrion, Korea’s most successful biosimilar maker,...
by Nam Doo-hyun  |  2017-08-22 17:01
라인
Samsung Bioepis, Takeda agree to develop biosimilar drugs
Samsung Bioepis and Takeda Pharmaceutical have signed a strategic collabora...
by Lee Han-soo  |  2017-08-21 20:45
라인
iNtRON Biotechnology adds trial for super bacteria drug
iNtRON Biotechnology has gained approval to start an additional Phase 1b cl...
by Marian Chu  |  2017-08-21 16:15
라인
Korea lags 3.8 years behind US in medical technology
There are technological gaps of 3.8 years in the medical area and 4.3 years...
by Nam Doo-hyun  |  2017-08-21 12:11
라인
‘Bio industry should prepare for Nagoya Protocol’
As the Nagoya Protocol, an international agreement on using foreign biologi...
by Nam Doo-hyun  |  2017-08-17 19:57
라인
Monsanto, ToolGen sign licensing agreement for CRISPR
ToolGen툴젠, a local genome engineering company, has signed a global license ...
by Constance Williams  |  2017-08-17 16:32
라인
Medytox’s botulinum toxin hits record-high sales in Q2
The second-quarter sales of Medytox메디톡스, a local biopharmaceutical company,...
by Constance Williams  |  2017-08-16 10:29
라인
Cha Biotech turns profitable 3 years after equity spinoff
Cha Biotech차바이오텍, the nation's largest stem-cell drug pipeline, turned ...
by Constance Williams  |  2017-08-14 16:34
라인
‘Stress resilience research to open new bio area’
The research to develop stress resilience application technology could lead...
by Nam Doo-hyun  |  2017-08-14 16:33
라인
Weak competitiveness hinders biomedicine export to China
Korea’s pharmaceutical companies should urgently strengthen their abilities...
by Nam Doo-hyun  |  2017-08-08 14:04
라인
‘Biomedicine is 1 of 6 areas Korea, US leaders should tackle’
Biomedicine has emerged as one of six fields that President Moon Jae-in has...
by Nam Doo-hyun  |  2017-08-07 17:08
라인
Medipost’s stem-cell therapy hits record-high sales
Medipost Co. announced Thursday that the monthly sales of its stem-cell tre...
by Constance Williams  |  2017-08-04 11:25
라인
Celltrion’s biosimilar takes 30% of Europe market share
Celltrion’s second antibody biosimilar product in Europe, Truxima, has regi...
by Constance Williams  |  2017-08-01 16:31
라인
5 universities publish most papers in prestigious bio journals
Which university has published the largest number of bio-related research p...
by Nam Doo-hyun  |  2017-08-01 16:18
라인
Medipost hits record sales in Q2
Medipost announced record sales in the second quarter of 2017 and positive ...
by Marian Chu  |  2017-08-01 10:00
라인
Celltrion applies for FDA approval of new anticancer biosimilar
Celltrion Healthcare is preparing to release its third biosimilar Herzuma i...
by Constance Williams  |  2017-07-31 15:04
라인
Samsung Bioepis, Merck launches biosimilar in US
Samsung Bioepis will launch its autoimmune disease biosimilar Renflexis (in...
by Marian Chu  |  2017-07-25 11:27
라인
Nature Cell to unveil stem cell drug for Alzheimer's disease
Biotechnology enterprise Nature Cell네이처셀 successfully administered “AstroSt...
by Constance Williams  |  2017-07-20 16:41
라인
Sillajen wins approval to start clinical trial in China
The China Food and Drug Administration (CFDA) has given the green light to ...
by Marian Chu  |  2017-07-20 13:43
라인
‘Stem cell therapy’s problem? No hit item yet’
Stem cells, which can be transplanted into a human body and differentiating...
by Nam Doo-hyun  |  2017-07-19 18:16
여백
여백
여백
Back to Top